CEN Biotech, Inc.
CENBF
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 41.55% | 97.75% | 58.44% | -110.81% | 62.68% |
| Total Depreciation and Amortization | 41.98% | -76.27% | -11.58% | 1.51% | 31.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.62% | -99.97% | -100.00% | 108.90% | -47.41% |
| Change in Net Operating Assets | -108.42% | -116.53% | -62.85% | -94.75% | -78.36% |
| Cash from Operations | -521.03% | -67.87% | 5.07% | -235.67% | 113.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 347.14% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -193.85% | -- |
| Cash from Investing | -- | -- | -- | -111.15% | 280.91% |
| Total Debt Issued | 1,781.82% | -79.79% | -- | -- | -98.23% |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -322.73% | 60.70% | -- | 466.67% | -98.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -149.26% | 1,020.79% | -5,172.73% | -1,311.76% | 2,575.61% |
